Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy US Physicalrapy stock
Learn how to easily invest in US Physicalrapy stock.
US Physicalrapy is a medical care facilities business based in the US. US Physicalrapy shares (USPH) are listed on the NYSE and all prices are listed in US Dollars. US Physicalrapy employs 3,507 staff and has a trailing 12-month revenue of around $536.2 million.
How to buy US Physicalrapy stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – USPH. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
What's in this guide?
US Physicalrapy stock price (NYSE: USPH)Use our graph to track the performance of USPH stocks over time.
US Physicalrapy shares at a glance
|Latest market close||$95.74|
|52-week range||$72.95 - $130.25|
|50-day moving average||$85.73|
|200-day moving average||$94.72|
|Wall St. target price||$102.33|
|Dividend yield||$1.61 (1.71%)|
|Earnings per share (TTM)||$2.99|
Buy US Physicalrapy stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy US Physicalrapy stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
US Physicalrapy price performance over time
|1 week (2023-01-20)||1.59%|
|1 month (2022-12-28)||22.04%|
|3 months (2022-10-28)||7.88%|
|6 months (2022-07-28)||-26.34%|
|1 year (2022-01-28)||0.57%|
|2 years (2021-01-28)||-23.63%|
|3 years (2020-01-28)||117.58|
|5 years (2018-01-26)||24.42%|
Is US Physicalrapy stock undervalued or overvalued?
Valuing US Physicalrapy stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of US Physicalrapy's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
US Physicalrapy's P/E ratio
US Physicalrapy's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, US Physicalrapy shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
US Physicalrapy's PEG ratio
US Physicalrapy's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0103. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into US Physicalrapy's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
US Physicalrapy's EBITDA
US Physicalrapy's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $80.5 million.
The EBITDA is a measure of a US Physicalrapy's overall financial performance and is widely used to measure a its profitability.
US Physicalrapy financials
|Revenue TTM||$536.2 million|
|Operating margin TTM||12.4%|
|Gross profit TTM||$117.2 million|
|Return on assets TTM||5.81%|
|Return on equity TTM||12.17%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
US Physicalrapy share dividends
Dividend payout ratio: 57.54% of net profits
Recently US Physicalrapy has paid out, on average, around 57.54% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.71% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), US Physicalrapy shareholders could enjoy a 1.71% return on their shares, in the form of dividend payments. In US Physicalrapy's case, that would currently equate to about $1.61 per share.
US Physicalrapy's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
US Physicalrapy's most recent dividend payout was on 15 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 17 November 2022 (the "ex-dividend date").
Have US Physicalrapy's shares ever split?
US Physicalrapy's shares were split on a 3:2 basis on 28 June 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your US Physicalrapy shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for US Physicalrapy shares which in turn could have impacted US Physicalrapy's share price.
US Physicalrapy share price volatility
Over the last 12 months, US Physicalrapy's shares have ranged in value from as little as $72.9461 up to $130.2519. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while US Physicalrapy's is 1.2871. This would suggest that US Physicalrapy's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
US Physicalrapy overview
U. S. Physical Therapy, Inc. , through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities.
US Physicalrapy in the news
With EPS Growth And More, U.S. Physical Therapy (NYSE:USPH) Makes An Interesting Case
U.S. Physical Therapy to Present at the 41st Annual J.P. Morgan Healthcare Conference
Shareholders in U.S. Physical Therapy (NYSE:USPH) are in the red if they invested three years ago
Frequently asked questionsWhat percentage of US Physicalrapy is owned by insiders or institutions?
Currently 1.85% of US Physicalrapy shares are held by insiders and 104.675% by institutions. How many people work for US Physicalrapy?
Latest data suggests 3,507 work at US Physicalrapy. When does the fiscal year end for US Physicalrapy?
US Physicalrapy's fiscal year ends in December. Where is US Physicalrapy based?
US Physicalrapy's address is: 1300 West Sam Houston Parkway South, Houston, TX, United States, 77042 What is US Physicalrapy's ISIN number?
US Physicalrapy's international securities identification number is: US90337L1089 What is US Physicalrapy's CUSIP number?
US Physicalrapy's Committee on Uniform Securities Identification Procedures number is: 90337L108
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert